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Summary
The critical developmental and genetic requirements of copper metabolism during embryogenesis are unknown. Utilizing
a chemical genetic screen in zebrafish, we identified small molecules that perturb copper homeostasis. Our findings reveal
a role for copper in notochord formation and demonstrate a hierarchy of copper metabolismwithin the embryo. To elucidate
these observations, we interrogated a genetic screen for embryos phenocopied by copper deficiency, identifying calamity,
a mutant defective in the zebrafish ortholog of the Menkes disease gene (atp7a). Copper metabolism in calamity is restored
by human ATP7A, and transplantation experiments reveal that atp7a functions cell autonomously, findings with important
therapeutic implications. The gene dosage of atp7a determines the sensitivity to copper deprivation, revealing that the
observed developmental hierarchy of copper metabolism is informed by specific genetic factors. Our data provide insight
into the developmental pathophysiology of copper metabolism and suggest that suboptimal copper metabolism may
contribute to birth defects.Introduction
Copper is an essential transition metal that plays a critical role
in the biochemistry of aerobic organisms. Enzymes utilize the
reactivity of this metal to undertake a series of facile electron
transfer reactions in a select number of metabolic pathways
essential for cellular respiration, iron oxidation, pigment forma-
tion, connective-tissue biogenesis, peptide amidation, neuro-
transmitter biosynthesis, and antioxidant defense (Pena et al.,
1999). The signs and symptoms of copper deficiency are the re-
sult of impaired function of these cuproenzymes. This reactivity
of copper also accounts for the toxicity of this metal when me-
tabolism is perturbed, and for this reason, specific pathways
have evolved for the intracellular trafficking and compartmental-
ization of copper (O’Halloran and Culotta, 2000; Rosenzweig,
2002). The inherited disorders of copper metabolism, Menkes
disease and Wilson’s disease, underscore both the essential
need for copper and the toxicity of this metal, and elucidation
of the molecular genetic basis of these diseases has enhanced
our understanding of the biochemical mechanisms of copper
metabolism (Culotta and Gitlin, 2001; Shim and Harris, 2003).
Considerable clinical and experimental data indicate that
copper is an essential nutrient for normal development. In chil-
dren withMenkes disease, an inability to acquire copper in utero
due to inherited loss-of-function mutations in the gene encoding
a copper-transport ATPase (ATP7A) results in metaphyseal
dysplasia, cerebellar degeneration, and severe failure to thrive
(Hamza et al., 2001; Voskoboinik and Camakaris, 2002). Simi-
larly, in a variety of mammals, copper deficiency during preg-
nancy due to either nutrient deprivation or genetic manipulation
results in embryo resorption or offspring with severe neurologicCELL METABOLISM 4, 155–162, AUGUST 2006 ª2006 ELSEVIER INC.impairment and presumed organogenesis defects in multiple
tissues including the heart and skeleton (Hamza et al., 2001;
Keen et al., 1998). While these data indicate a role for specific
transporters and chaperones in supplying copper to the devel-
oping fetus (Mercer and Llanos, 2003), the mechanisms and
timing of developmental events dependent on copper metabo-
lism remain unknown due to the lack of models affording facile
genetic and biochemical analysis during embryogenesis.
We hypothesized that the zebrafishmight provide advantages
for the analysis of coppermetabolismduring vertebrate develop-
ment. The optical clarity and rapid external development of em-
bryos permit detailed characterization of deficient phenotypes
from themoment of fertilization. Furthermore, zebrafish embryos
have been used in small-molecule screens, permitting the iden-
tification of specific developmental phenotypes and the associ-
ated genetic pathways (Peterson et al., 2000; Stern et al., 2005;
Zon and Peterson, 2005). In this current study, we have utilized
chemical genetics combined with a genetic screen (Solnica-
Krezel et al., 1994) to elucidate the critical developmental and
genetic requirements of copper metabolism during embryogen-
esis. Our findings provide insight into the developmental patho-
physiology of copper metabolism and suggest an experimental
approach toward elucidating the biology of gene-nutrient inter-
action essential for early human development.
Results
Small molecules allow the specific manipulation
of copper during development
To obtain precise, temporal control of copper metabolism
during development, we determined the minimum copperDOI 10.1016/j.cmet.2006.05.001 155
A R T I C L Econcentration in the zebrafish embryo to be 0.5–1.0 mM based
on data from oocytes (Riggio et al., 2003). This internal copper
pool largely present within the yolk sac is entirely sufficient for
embryonic development, as treatment of developing embryos
with nonpermeable copper chelators was without effect (data
not shown). To identify tools with which to alter this internal cop-
per pool, we employed a chemical genetic screen, reasoning
that small molecules interfering with copper metabolism would
prevent melanin pigmentation by blocking the activity of tyrosi-
nase, a copper-containing oxidase required for melanin-based
pigment in the zebrafish embryo (Rawls et al., 2001). The spec-
ificity of this effect was determined by examining these embryos
for recovery of tyrosinase activity following the addition of exog-
enous copper (Figure 1).
Of the small molecules screened (see Table S1 in the Supple-
mental Data available with this article online), seven of diverse
chemical structure prevented melanin pigmentation in a manner
entirely reversible by the addition of exogenous copper (Table
S2). These small molecules each yielded an identical and strik-
ing pleiotropic phenotype, as illustrated in Figure 1, following
exposure to neocuproine. Each drug gave the same phenotype
at the same time of treatment. Although there were differences
in the effectiveness of the compounds as reflected by the
doses used, in every case, the identical hierarchy of phenotypes
was observed (see below). These small molecules did not affect
melanocyte differentiation or migration as determined by
in situ hybridization with a melanocyte marker and did not di-
rectly inhibit tyrosinase as determined by an in-gel assay (data
not shown). Consistent with these experimental findings, review
of the literature revealed that each molecule has been associ-
ated with copper-chelating activity. Furthermore, none of these
compounds has reported teratogenic activity, supporting the
concept that the phenotypes observed arise directly from cop-
per deficiency. The identification in this screen of two drugs
used in clinical medicine raises the intriguing possibility that un-
identified alterations in nutrient metabolism may underlie the
therapeutic or toxic mechanisms of additional prescription
drugs.
Examination of the copper-deficient phenotype in greater de-
tail was undertaken following treatment of developing embryos
with the minimum dose (10 mM) of neocuproine that gave the
most robust phenotype. In the zebrafish embryo, the notochord
consists of a collection of vacuolated cells surrounded by a
sheath, adjacent to the dorsal aorta and the developing floor
plate (Figure 2A, left panel). Copper deficiency profoundly al-
tered notochord development, resulting in an undulating struc-
ture that contains vacuolated cells but was interrupted by addi-
tional tissue structures and surrounded by a thickened floor
plate and deformed aorta (Figure 2A, right panel). Further phe-
notypic analysis of copper-deficient embryos also revealed im-
paired cartilage and vascular development (Figures 2B and 2C),
an absence of hematopoiesis (Figure 2D), and impaired neuro-
genesis affecting both the midbrain-hindbrain region of the de-
veloping brain (Figure 2E) as well as the primary motor neurons
(Figure 2F). Interestingly, the hematopoietic defect involved
multiple cell lineages (data not shown) analogous to what is ob-
served in mammalian copper deficiency, although the mecha-
nisms of this effect are not well understood. These identical
phenotypes were observed with each of the other small mole-
cules identified in this screen and in all cases were prevented
by treatment with 25 mM copper chloride dissolved in the egg156water at 5 hr postfertilization (hpf) but not other transition metals
including zinc, iron, cobalt, cadmium, and molybdenum (data
not shown). These findings also reveal that copper readily enters
the embryo from the surrounding water, presumably entering
cells through plasma membrane transport, although the route
and mechanism of this process are unknown.
These phenotypes of copper deficiency were readily demon-
strable following relatively short and early incubation times with
the small molecules, suggesting a mechanism of action that
permanently renders copper inaccessible to the embryo (Fig-
ure 3). Surprisingly, careful observation of embryos treated for
brief time periods (Figures 3A–3D) or with submaximal doses
of drugs (Figures 3E and 3F) revealed that the threshold of
drug for each aspect of the phenotype differed. Thus, while un-
treated embryos had normal notochords andmelanin pigmenta-
tion (Figure 3A), treatment for 10 min in 10 mM neocuproine
resulted in absence of melanin pigment but a normal notochord
(Figure 3B). When such treatment was extended to 20 min, the
notochord was clearly abnormal (Figure 3C), and by 60 min,
the entire phenotype including the enlarged hindbrain ventricle
was observed and did not worsen with longer treatment (Fig-
ure 3D). Similarly, embryos incubated continuously starting at
3 hpf in 100 nM neocuproine appeared normal, while treatment
with 1 mM drug prevented pigmentation but did not affect the
notochord. These findings reveal a hierarchy of copper distribu-
tion within the developing embryo that may reflect specific
metabolic adaptations based upon the availability of this metal
and the essential requirements of each diverse biochemical
pathway.
Figure 1. Schematic of the small-molecule screen for drugs perturbing copper
metabolism
A) Embryos from wild-type zebrafish were arrayed in a 96-well format and treated
with drugs at 5 mM beginning at 3 hr postfertilization (hpf). At 30 hpf, the embryos
were assayed for the development of melanin pigment. In a second screen, em-
bryos were again exposed at 3 hpf to drugs that abrogated melanin formation
but this time were supplemented with 25 mM CuCl2. In this screen, all drugs that
prevented pigmentation in a manner reversible by the addition of exogenous
copper were considered as perturbing copper homeostasis.
B and C) As compared to wild-type embryos (B), copper-deficient embryos
treated with neocuproine (C) lacked pigment and displayed a strikingly wavy
notochord and enlarged hindbrain ventricle (arrowheads).CELL METABOLISM : AUGUST 2006
Zebrafish copper metabolismFigure 2. Copper-deficient embryos display a pleiotropic phenotype
DIC image of notochord from a control embryo at 28 hpf (A, left) reveals normal development of the central canal (c), floor plate (f), notochord (n), and aorta (a), while a
copper-deficient embryo of the same age treated with neocuproine (NeoC) (A, right) shows malformations including distorted floor plate (arrow), undulating notochord,
additional tissue structures (arrowhead), and displaced aorta. Alcian blue staining of 96 hpf control (B, left) and copper-deficient (B, right) embryos reveals reduced cartilage
formation with compression (arrowhead) and impaired jaw elongation. At 48 hpf, fli1:GFP copper-deficient embryos (C) exhibit disorganization of the intersegmental vas-
culature with microaneurysms (arrowheads). O-dianisidine staining at 72 hpf (D) reveals a marked decrease in hematopoiesis (arrowheads) in a copper-deficient embryo
(top) compared to control (bottom). DIC image at 32 hpf reveals an abnormal midbrain-hindbrain boundary (arrowheads) in copper-deficient (E, right) versus control (E, left)
embryos. Antibody staining (Znp-1) reveals loss of primary motor neurons (arrow) and associated axons (arrowhead) in copper-deficient (F, right) versus control (F,left)
embryo at 28 hpf.Copper deficiency phenocopies calamityvu69
To further understand the molecular genetic basis of such meta-
bolic adaptations in copper homeostasis during embryogenesis,
we next interrogated a genetic screen for mutant embryos phe-
nocopiedbycopperdeficiency.UtilizinganENU-mutagenesisge-
netic screen, we identified calamity (calvu69) (Figures 4A and 4B),
a recessive lethal mutant with a striking resemblance (particularly
in its lack of melanin pigment and wavy notochord) to the chem-
ically induced copper-deficient phenotype. Initial mapping ex-
periments localized cal to a region of chromosome 14, 3.5
centimorgans from the knypek/glypican 4 locus (Topczewski
et al., 2001), in proximity to a gene suggested by a BLAST search
to encode a copper-transport ATPase. Phylogenetic analysis
(Figure 4C) and sequence comparison (Figure S1) indicate that
this ATPase identified on chromosome 14 is the ortholog of the
humanMenkesdiseasegene,ATP7A.AsecondzebrafishATPase
identified in the BLAST search is the ortholog of the human
Wilson’s disease gene, ATP7B (Figure 4C). As Menkes disease
is inpart characterizedby reducedmelanin pigmentation,wecon-
sidered atp7a to be a candidate gene for the locusmutated in cal.
Sequenceanalysis of the zebrafish atp7agene from calmutant
embryos identified a mutation creating a cryptic splice acceptor
in the intron before exon 9 (Figure 4D), inserting seven additional
bases into the mRNA and causing a frameshift and premature
stop codon at amino acid 674 of 1482 (Figure 4E). The resulting
open reading frame, if translated, would lack all transmembrane
and catalytic domains and would therefore be nonfunctional.
Restriction digestion of a fragment that was PCR amplifiedCELL METABOLISM : AUGUST 2006from zebrafish atp7a cDNA revealed the absence of wild-type
message in cal homozygous mutant embryos and a mixture of
wild-type and mutant mRNA in their siblings (Figure 4F).
The expression pattern of zebrafish atp7a correlates
with observed phenotypes
In situ hybridization with a probe to zebrafish atp7a revealed
ubiquitous and early expression (Figure 5A). A sense-control
probe yielded no staining (Figure 5B). Later, significant expres-
sion was observed in the developing notochord, with ubiquitous
weaker expression in other tissues of the embryo (Figure 5C).
Sections revealed atp7a expression along the ventricles (Fig-
ure 5D) and in the distal notochord (Figure 5E) at 24 hpf. These
patterns of expression correlate with the observed cal pheno-
type. A probe to the zebrafish ortholog of the Wilson’s disease
protein at 5 days postfertilization (dpf) revealed expression in
the liver (Figure 5F), consistent with the known expression pat-
tern of ATP7B in mammals and demonstrating the conservation
of liver-specific expression across metazoans over millions of
years of evolution.
Rescue of calamity with human ATP7A and assessment
of cell autonomy
To confirm the role of atp7a deficiency in the cal phenotype,
synthetic RNA encoding human ATP7A was injected into the
zygotes from a cal heterozygous cross, significantly suppress-
ing pigmentation and notochord defects in genotypically mutant
embryos (Figure 6A). In three separate experiments, 72% of cal157
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while the remainder displayed some normalization of pigmenta-
tion and notochord structure. Mechanisms of iron homeostasis
have been conserved between humans and zebrafish over mil-
lions of years of evolution (Donovan et al., 2000). The restoration
of complex developmental phenotypes following expression in
the zebrafish of the orthologous human copper transporter
similarly demonstrates the functional evolutionary conservation
of the genetic and biochemical mechanisms of copper metabo-
lism and provides for a unique experimental system to assess
the function of genetic variants of the human Menkes copper
transporter.
The availability of a vertebrate model of Menkes disease in
an organism where embryonic cell transplantation is possible
allowed for a direct analysis of the requirement for atp7a in
inter- and intracellular copper transport during development.
Therefore, we transplanted cells from wild-type donors into cal
embryos to assess the cell autonomy of the genetic defect.
cal2/2 embryos lack melanin pigmentation (Figure 6C), while in
contrast, 35 out of 48cal embryos from three separate transplan-
tation experiments exhibited pigmented donor melanophores or
retinal pigment epithelium (Figures 6D–6F). Most interestingly,
these transplantation experiments reveal that zebrafish Atp7a
acts cell autonomously in melanocytes, suggesting that it is re-
quired for proper copper utilization in individual cells and may
Figure 3. Small-molecule effects are rapid, saturable, and dose and time
dependent
Examination of embryo at 48 hpf following no treatment reveals normal melanin
pigmentation and notochord (A), while treatment with 10 mM neocuproine for
10 min at 3 hpf abrogates melanin pigmentation but does not affect the notochord
(arrows) (B). Treatment with 10 mM neocuproine for 20 min starting at 3 hpf reveals
both abrogated pigmentation, enlarged hindbrain ventricle (arrowhead), and
a wavy notochord (arrows) (C). Treatment with 10 mM neocuproine for 60 min at
3 hpf does not increase the severity of the pigment, notochord (arrows), or ventricle
(arrowheads) phenotype (D), indicating that the effect is saturable. Untreated
48 hpf embryo (E) shows the normal distribution of melanocytes with melanin pig-
mentation (inset, arrowhead) and normal notochord, while treatment at 3 hpf with
500 nM neocuproine (one-twentieth of the dose of neocuproine resulting in the
complete phenotype) (F) impairs only melanin pigmentation (inset, arrowhead).158not be essential for copper transport from the yolk sac or within
the embryo.
Gene dosage of zebrafish atp7a determines
the sensitivity to copper deprivation
The developmental hierarchy of copper metabolism observed in
embryos treated with variable time or dose exposure to small
molecules as well as the cell autonomy observed in the trans-
plantation experiments suggests a complex developmental
program of copper metabolism dependent upon both the avail-
ability of copper and the function of atp7a. To elucidate this
complexity of gene-nutrient interaction, we took advantage of
our small-molecule screen to precisely modulate copper avail-
ability in a specific genetic context. While 100 nM neocuproine
did not affect melanin pigmentation in wild-type embryos (Fig-
ure 7A), this dose prevented melanin pigment in cal heterozy-
gotes (Figure 7B) and worsened the notochord phenotype in
cal homozygotes (compare Figure 4B and Figure 7C). To more
precisely examine this effect, we next utilized an antisense mor-
pholino oligonucleotide (MO) directed against a splice junction
in the atp7a transcript at a dose that resulted in no apparent phe-
notype and preserved some wild-type message (Figure S2).
Comparison of control MO-injected embryos (Figures 7D–7G)
with atp7a MO-injected embryos (Figures 7H–7K) at increasing
doses of neocuproine revealed that knockdown of atp7a strik-
ingly increased the sensitivity of zebrafish embryos to develop-
mental copper deficiency. Most notably, a dose of neocuproine
that affected neither pigmentation nor the notochord (Figure 7E)
and a dose of atp7a MO that yielded no phenotype (Figure 7I)
Figure 4. The zebrafish mutant calamityvu69 is defective in the zebrafish ortholog
of the Menkes disease gene and is phenocopied by copper deficiency
A and B) Copper-deficient embryo (A) and a cal homozygote (B) at 48 hpf.
C and D) Phylogeny of copper-transport P type ATPases (C) displayed as maxi-
mum-likelihood tree with bootstrap values as shown. Aligned nucleotide sequence
chromatograms (D) from genomic DNA from a portion of the atp7a gene fromwild-
type, cal heterozygote, and mutant embryos reveals a T/A transversion (box) in
the intron 50 to exon 9.
E) Analysis of cDNA reverse transcribed frommRNA reveals that thismutation acts
as a cryptic splice acceptor causing the insertion of seven nucleotides (TTCTCAG)
into the mRNA.
F) Restriction digests of a region amplified from atp7a cDNA reveal a novel DdeI
site corresponding to the 7 bp insertion at the cal locus (arrowheads).CELL METABOLISM : AUGUST 2006
Zebrafish copper metabolismcaused a severe phenotype when combined (Figure 7J). Taken
together, these findings support the hypothesis that the gene
dosage of atp7a informs the sensitivity of each phenotype to
copper deficiency.
Discussion
In this current study, we have utilized chemical genetics com-
binedwith a genetic screen to elucidate the critical developmen-
tal and genetic requirements of copper metabolism during
embryogenesis. Our findings reveal an adaptive hierarchy of
coppermetabolismasevidenced, for example, by thenotochord
abnormality, a lethal defect for the developing embryo, that is
preferentially preserved when copper availability is limited (Fig-
ure 3). Presumably, all such developmental events ultimately de-
pendon the incorporation of copper into specific cuproenzymes,
and thus, the mechanisms of this adaptive metabolic hierarchy
must arise from differences in either the localization of copper
to embryonic structuresor the relative affinity of intracellular cop-
per transporters, chaperones, or specific cuproenzymes for this
metal (Bertinato and L’Abbe, 2004). This differing threshold of
drug for each aspect of the phenotype is not due to differences
in tissue penetration, as treatment is initiated prior to any signif-
icant differentiation (Figure 3). Our genetic studies suggest that
the sensitivity of each phenotype to copper deficiency is deter-
mined by gene dosage of atp7a (Figure 7), while the transplanta-
tion experiments reveal that this sensitivity is cell autonomous
such that any cell with sufficient Atp7a for the given availability
of copper will produce active cuproenzymes (Figure 6). These
observations suggest that in the developing embryo, as copper
becomes limiting, tissues expressing higher levels of Atp7a
wouldbeadvantaged, and in support of this concept, in situ anal-
ysis reveals that atp7a mRNA is most abundantly expressed in
the notochord and ventricles (Figure 5), paralleling the observed
hierarchy of sensitivity to copper deficiency.
The notochord is the defining structure of chordates and has
essential roles in vertebrate development as a skeletal element
Figure 5. Expression pattern of atp7a via in situ hybridization
Anterior (a), posterior (p), and dorsal (d) are as indicated.
A) atp7a message is present in all cells at 3 hpf.
B) Staining is specific, as a sense-control probe does not show staining.
C) At 8 somites, atp7a is expressed most abundantly in the notochord and is
expressed ubiquitously at lower levels.
D and E) Sectioning at 24 hpf reveals staining along the ventricle (D) (arrowhead)
and in the distal notochord (E) (arrow).
F) In situ analysis of atp7b reveals expression in the liver (arrowhead) in a 5 dpf
embryo as shown in this dorsal view.CELL METABOLISM : AUGUST 2006and in the patterning of the surrounding tissues (Stemple, 2005).
Our data demonstrate that copper is essential for notochord
formation (Figure 2) and raise the interesting possibility that
some of the vascular and neurologic abnormalities observed
in the offspring of copper-deficient animals and patients with
Menkes disease may result from patterning defects secondary
to notochord abnormalities. While we have not elucidated the
mechanisms of impaired notochord formation in copper defi-
ciency, recent studies in Xenopus laevis demonstrate abundant
expression of lysyl oxidases within the developing notochord
(Geach and Dale, 2005), suggesting that we may have uncov-
ered a role for these cuproenzymes in connective-tissue biosyn-
thesis critical for notochord development (Csiszar, 2001). In
mammalian cells, lysyl oxidases are synthesized within the se-
cretory pathway of mesenchymal cells where copper incorpora-
tion is dependent upon ATP7A (Voskoboinik and Camakaris,
2002), a finding that would support the hypothesis that the
abnormal notochord formation in cal (Figure 4) arises from
impaired lysyl oxidase activity. In humans, the notochord even-
tually becomes ossified in regions forming vertebrae and con-
tributes to the nucleus pulposis of the intervertebral discs
(Linsenmayer et al., 1986). Our observations that copper is es-
sential for notochord structure raise the intriguing possibility
that suboptimal copper availability due either to dietary factors
or genetic variation in ATP7A or lysyl oxidases during the period
of notochord formation or subsequent ossification may contrib-
ute to structural birth defects such as congenital scoliosis in
which axial skeletal structure is impaired (Blank et al., 1999).
calamity is a newly described zebrafish mutant and a useful
model of Menkes disease. Our data demonstrate that cal is phe-
nocopied by copper deficiency (Figure 4), a finding to be antic-
ipated in any legitimatemodel of this disorder. Importantly, while
a well-established mammalian model of this disease exists in
the mottled mouse, the rapid external development of the opti-
cally clear zebrafish embryo permits a precise characterization
Figure 6. Rescue of cal with human ATP7A and transplantation experiments
The calamity mutant phenotype (A) is rescued by injection with synthetic RNA en-
coding the human Menkes ATPase (B). Although cal embryos display a complete
lack of melanin pigment at 48 hpf (C), transplantation of rhodamine-dextran-in-
jected wild-type cells into cal embryos (D) yields embryos mosaic for pigmented
melanophores (arrows). In all cases, the pigmented cells shown here in the retinal
epithelium (E) correspond to the rhodamine-labeled donor cells as detected by
fluorescence for CY3 in this same epithelium (F).159
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cellular and genetic manipulations such as transplantation
(Figure 6) that are not possible with in utero development. In-
deed, our observation of the cell autonomy of this disorder sug-
gests that therapeutic strategies focused upon tissue-specific
gene replacement may be a legitimate approach in affected pa-
tients. Furthermore, consistent with the observation of cell au-
tonomy, exogenous CuCl2 did not improve the cal phenotype.
The discovery of a zebrafish model of Menkes disease now per-
mits high-throughput chemical suppression screens (Peterson
et al., 2004; Stern et al., 2005) for compounds that restore cu-
proenzyme function in the setting of a deficiency of the Menkes
ATPase, an approach also not possible with the existing murine
models. Such drugs would be of immediate clinical relevance.
The relevance of nutrition during development is revealed
by recent data highlighting the importance of folate intake be-
fore and during pregnancy for preventing neural tube defects
(Copp et al., 2003). Despite these observations, the metabolic
factors that place specific pregnancies at higher risk remain un-
known. Having described the gene-nutrient interactions of cop-
per metabolism and atp7a during development, our findings
demonstrate the potential of chemical and genetic screens to
elucidate the metabolic and genetic interplay of other nutrients
that may provide insight into the roles of suboptimal nutrition
and genetic variation in human birth defects.
Experimental procedures
Zebrafish maintenance and analysis
SJD and C32 strains were utilized to obtain large numbers of synchronously
in vitro-fertilized zebrafish eggs. Embryos were maintained and staged as
described previously (Kimmel et al., 1995). The fli1:EGFP transgenic fish
are described elsewhere and were generously provided by Brant Weinstein
(Motoike et al., 2000). calamityvu69 arose from an ENU-mutagenesis
screen for mutants defective in gastrulation and is in the AB/TL background
(Solnica-Krezel et al., 1994). Eggs from individual females were collected,
Figure 7. Interaction of atp7a dosage and developmental copper deficiency
A and B)Wild-type embryos appear normal in 100 nM neocuproine (A); cal hetero-
zygotes display loss of all melanin pigment at this same dose (B).
C) The pleiotropic phenotype of copper deficiency is observed in all cal homozy-
gotes in 100 nM neocuproine.
D–K) Embryos injected with control MO (D–G) display a phenotypic dose-re-
sponse curve in neocuproine of the notochord (arrowheads) and melanin pigment
(arrows) that is altered in embryos injected with atp7a-targeted MO (H–K). All
embryos were treated continuously from 3 hpf with the indicated dose of drug.160fertilized in vitro with sperm, and allowed to develop at 28.5C. Synchronized
wild-type developing embryos were arrayed as three embryos per well in
96-well plates containing 180 ml of embryo buffer supplemented with meth-
ylene blue and ampicillin. Differential interference contrast images (DIC)
were obtained using an Olympus IX71 microscope fitted with a Nomarski
objective, and images were acquired with a TH4-100 camera and Olympus
MicroSuite software. Fluorescently labeled embryos were visualized utilizing
a laser scanning confocal microscope (BX61WI FV500; Olympus) equipped
with argon 488 and krypton 568 lasers utilizing the 103 objective. Represen-
tative fish were imaged using identical confocal settings, and serial Z stacks
were acquired using a pinhole aperture of 150 mM. Images were collected
with FluoView software (Olympus).
Pharmacologic compounds
Approximately 250 small molecules representing all of the major classes of
compounds used in clinical medicine as well as a series of known metal che-
lators were purchased from Sigma, prepared as 5 mg/ml stocks in dimethyl
sulfoxide, and then transferred as 20 ml aliquots into individual wells, followed
by dilution to ranges from 1 mM to 1 nM for each drug (Table S1). In addition,
an array of pharmacologically active small molecules (LOPAC1280, Sigma)
was utilized at 1000-fold dilution for a final concentration of 10 mM. All small
molecules were added to the arrayed zebrafish embryos at the 256-cell stage
unless otherwise stated, and embryos were examined with an Olympus
SZX12 stereomicroscope at 1, 2, and 3 dpf. Phenotypes were recorded
when exhibited by each embryo in the well (Peterson et al., 2000). For those
drugs identified as potentially interfering with copper homeostasis on the
basis of lack of melanin pigmentation at 2 dpf, this analysis was repeated
in the presence of 25 mM CuCl2 dissolved in the media.
Immunohistochemistry and in situ hybridization
Embryos raised in phenylthiourea (PTU) were dechorionated and fixed in 4%
paraformaldehyde/PBS for 4 hr at room temperature or overnight at 4C. Em-
bryos were washed in PBS and then water and were permeabilized for 7 min
in 220C acetone, followed by washes in water. The embryos were then
blocked for 30 min in PBS/1% DMSO/0.05% Tween 20/10% FBS and incu-
bated overnight in Znp-1 (1:500) antisera (Developmental Studies Hybridoma
Bank) in the blocking solution. The antibody was removed and the embryos
were washed extensively for 2 hr (Schulte-Merker et al., 1992). Staining was
carried out using the VECTASTAIN anti-mouse IgG peroxidase assay (Vector
Laboratories) according tomanufacturer’s instructions. To generate an in situ
probe, a 1.6 kb region corresponding to nt 807–2467of the zebrafish atp7a
cDNA was PCR amplified and used as template to prepare a probe using
the DIG-labeling kit (Roche). Various stage embryos were collected and fixed
in fresh 4% paraformaldehyde overnight at 4C, dechorionated, dehydrated
with an ascending methanol series (30%, 50%, and 100%), and stored
in methanol at 220C overnight. In situ hybridization was performed as
previously described (Thisse et al., 1993).
Alcian blue staining
Embryos at 4 dpf raised in PTU were fixed overnight in 3.7% formaldehyde/
PBS, rinsed in PBT (PBS, 0.1% Tween 20), and stained overnight in 0.1%
Alcian blue (Sigma) dissolved in 80% ethanol and 20% glacial acetic acid.
Embryos were then rehydrated in ethanol:PBT to 100% PBT and cleared in
0.05% trypsin in PBS for 1.5 hr at room temperature, followed by several
washes in PBS. Embryos were gradually transferred to 70% glycerol and
visualized (Detrich et al., 2004).
Dianisidine staining
Dechorionated 3 dpf embryos were stained at room temperature for 15 min
in 2.0 ml o-dianisidine (100 mg/70 ml ethanol), 0.5 ml 0.1 M acetate buffer
(pH 4.7), 2.0 ml deionized water, 0.1 ml hydrogen peroxide (30%) followed
by rinsing in water (Iuchi and Yamamoto, 1983).
Tyrosinase assay
Ninety-six hours postfertilization embryos were deyolked and lysed in protein
extraction buffer (10 mM Tris [pH 7.4], 2% Triton X-100) plus protease inhib-
itor cocktail (Calbiochem) for 30 min on ice. One hundred micrograms of
lysate without b-mercaptoethanol or boiling was run on a 10% SDS gel
and assayed for tyrosinase activity as described (Orlow et al., 1993).CELL METABOLISM : AUGUST 2006
Zebrafish copper metabolismcalamity sequence analysis
RNA was isolated from 48 hpf cal mutant and wild-type siblings using the
Trizolmethod (Invitrogen). First-strand cDNAwas generated using the Super-
Script III kit (Invitrogen). Gene-specific PCRprimerswere created using avail-
able genomic cDNA sequence and were used to amplify two fragments en-
compassing the zebrafish atp7a open reading frame, which were then cloned
into the TA cloning vector pCRII (Invitrogen). The insert was sequenced using
internal primers and primers to the flanking vector sequence. A 798 kb PCR
product surrounding the 7 bp insertion was amplified from cal mutant cDNA
and wild-type sibling cDNA, digested with DdeI (NEB) for 3 hr, and run on
a5%polyacrylamidegel. Phylogenetic analysis of zebrafishcopper-transport
P type ATPases was determined using neighbor-joining and maximum-
likelihood methods to construct trees (Mellgren and Johnson, 2005). Acces-
sion numbers were as follows: Homo sapiens ATP7A, gi:1351993; Homo
sapiens ATP7B, gi:55957861; D. rerio atp7a, gi:70724999; D. rerio atp7b,
FGENESH00000051998; D. melanogaster atp7, gi:45446920.
Cloning of zebrafish atp7a
Putative exons encoding the zebrafish atp7a gene were found by TBLASTN
from the Ensembl zebrafish genome website (http://www.ensembl.org/
Danio_rerio/index.html) available as of January 2005. 50 RACE was used to
identify the first exon. The primers used were forward primer 50-CGAAG
AATGGCGCTGAGCAC-30 and reverse primer 50-GCTCCAGAGACCCTCAG
ACT-30. These primers were used to amplify from 32 hpf cDNA, and the re-
sulting product was completely sequenced. Alignment of the zebrafish
atp7a amino acid sequence to human sequences was performed using
ClustalW (Thompson et al., 1994).
Morpholino and mRNA injection
Amorpholino oligonucleotide (MO) (Nasevicius and Ekker, 2000) 50-CAAGTC
AAGCAGACCTGTTTGCAAT-30 targeting the splice donor site following exon
16 (Gene Tools) was synthesized, dissolved in Danieau’s buffer/phenol red,
and injected into one to four cell embryos as 12 ngMO per embryo. A second
MO (50-TTAGTGCTCAGCGCCATTCTTCGTC-30) targeting the start codon of
atp7a yielded a similarly increased sensitivity to neocuproine. A standard
control MO (Gene Tools) was injected in parallel at the same dose. Synthetic
RNA encoding the human Menkes ATPase was generated from pJFM19
using the T7 mMESSAGE mMACHINE kit (Ambion) and polyadenylated
with the Poly(A) Tailing Kit (Ambion). Two hundred picograms per embryo
was injected.
Transplantation
Rhodamine dextran was injected as a lineage tracer into one-cell wild-type
embryos. At the sphere stage, approximately 30 donor cells below the animal
pole were transplanted into zygotes of the same age from cal heterozygous
parents (Lin et al., 2005).
Supplemental data
Supplemental Data include two figures and two tables and can be found with
this article online at http://www.cellmetabolism.org/cgi/content/full/4/2/155/
DC1/.
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